Previous 10 | Next 10 |
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
What we're witnessing right now is truly unprecedented, both in mitigation response terms to the spread of coronavirus disease 2019 (COVID-19) and the roiling of financial markets around the globe . As of March 15, this lung-focused illness had claimed the lives of nearly 5,800 people wor...
A very quiet and tasteful way to be famous is to have a famous relative. Then you can not only be nothing, you can do nothing too ."- P. J. O'Rourke It was a wild week for investors as the markets went through their most volatile week of trading since the 2008 financial crisis. Sports lea...
The Magic Formula by Joel Greenblatt has been a subject of my writing in the past . What used to bug me is that the screen included many microcaps and odd stocks such as royalty trusts. Therefore I decided to set the minimum market cap at $2.5bn. Overall, I am pleased with the new result be...
I devoted a lot of attention to BioCryst Pharmaceuticals ( BCRX ) over the last 10 months but have not invested yet. That’s because of the specific set of circumstances the company was in over that time. First, I believed that the BCX7353 (berotralstat) phase 3 readout had more risk...
- Ahead of Rare Disease Day, new support becomes available to the rare community - Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the launch of the Alexion Charitable Foundation to provide further support for the rare disease community and for local communities which the...
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that management will present at the Cowen Health Care Conference in Boston, MA on Tuesday, March 3rd, 2020 at 9:20 a.m. ET. An audio webcast of the presentation will be available live. You can access the webcast at: http://ir.alexion....
Yesterday (Monday, Feb. 24), US stocks suffered their worst trading day in two years. New coronavirus cases that were reported outside China have rattled investors and dashed earlier hopes that the outbreak had already been, or is about to fairly quickly be, contained. Following a wave o...
Introduction Now that we are in the back half of Q1, I have run out of time to do a full article on every biotech I own, have sold out of, or in other ways have discussed in the past two or so years on Seeking Alpha . So, I would like to provide commentary on several of these stocks, and al...
Buy The Dip On Coronavirus Fears With the S&P 500 and Nasdaq trading at record highs, we are amazed to see nearly 80% of the companies on our Watch List (over 200 stocks) trading over -20% below their highs made in the past five years. We have already demonstrated to what extent t...
News, Short Squeeze, Breakout and More Instantly...
Alexion Pharmaceuticals Inc. Company Name:
ALXN Stock Symbol:
NASDAQ Market:
Alexion Pharmaceuticals Inc. Website:
AstraZeneca (NASDAQ: AZN) hopes to soon close its planned acquisition of Alexion Pharmaceuticals (NASDAQ: ALXN) . The only hurdle left to jump is obtaining approval from United Kingdom regulators. In this Motley Fool Live video recorded on July 7 , Motley Fool contri...
This week, pharma and biotech giant AstraZeneca (NASDAQ: AZN) cleared its final hurdle in the proposed acquisition of orphan drug pharma company Alexion Pharmaceuticals (NASDAQ: ALXN) when it announced that the deal had received clearance from the United Kingdom's Compet...